Drug resistance during chemotherapy is the major obstacle to the successful treatment of
many cancers. Here, we report that inhibition of NF-E2-related factor 2 (Nrf2) may be a …

Radiotherapy induces and promotes innate and adaptive immunity in which host STING
plays an important role. However, radioresistance in irradiated tumors can also develop, …

Type II endometrial cancer, which mainly presents as serous and clear cell types, has
proved to be the most malignant and recurrent carcinoma among various female genital …

The clinical utility of stimulator of interferon genes (STING) agonists has been limited due to
poor tumour-targeting and unwanted toxicity following systemic delivery. Here we describe a …

OBJECTIVE: The goal of this work was to determine whether exposure to estrogen following
treatment of low-grade endometrial stromal sarcomas affects clinical outcome. METHODS: …

PURPOSE To evaluate the impact of two different intraperitoneal (IP) chemotherapy
regimens on progression-free survival (PFS) among women with newly diagnosed advanced …

Most studies focus on how intestinal microbiota influence cancer immunotherapy through
activating gut immunity. However, immunotherapies related to innate responses such as CD47 …

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is an oncofetal protein highly
expressed in fetal tissue and malignant tumors but rarely found in adult benign tissues. The aim …

The cellular expression of pituitary gonadotropin receptors in gonadal tissues is poorly defined
because of the lack of suitable reagents. In this study, we developed in situ hybridization …

Ovarian low-grade serous carcinomas are thought to evolve in a stepwise fashion from
ovarian epithelial inclusions, cystadenomas, and borderline tumors. The current study was …